Stocks
FibroGen (FGEN) ROE US GAAP (year values) |
||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | |||
| ROE, % | ? | -44.8% | -139.2% | -139.2% | 1 377% | 139.2% | 72.4% | |
| Changes by years, y/y, % | -30pp | -94pp | 0pp | +1 516pp | -1 237pp | |||
FibroGen. ROE, %
FibroGen. ROE, changes, pp
FibroGen (FGEN) ROE US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| ROE, % | ? | 316.5% | 187.9% | 139.6% | 105.4% | 72.4% | 72.4% | |
| Changes by years, y/y, % | +530pp | +1 568pp | -1 237pp | -528pp | -244pp | |||
| Changes by quarters, q/q, % | -316pp | -129pp | -48pp | -34pp | -33pp | |||
